In situ directed evolution of γ-glutamyl kinase in Corynebacterium glutamicum S9114 by innovative EvolvR-mediated mutagenesis and rare codon-based selection to increase L-proline production
IF 3.7 3区 生物学Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Jian-Zhong Xu , Feng Zhang , Kai Wang , Shuo Wan , Wei-Guo Zhang
{"title":"In situ directed evolution of γ-glutamyl kinase in Corynebacterium glutamicum S9114 by innovative EvolvR-mediated mutagenesis and rare codon-based selection to increase L-proline production","authors":"Jian-Zhong Xu , Feng Zhang , Kai Wang , Shuo Wan , Wei-Guo Zhang","doi":"10.1016/j.bej.2025.109982","DOIUrl":null,"url":null,"abstract":"<div><div>An efficient evolution and selection system is vital for constructing the high added-value products hyper-producers in fermentation industry. Herein, an innovative EvolvR-mediated mutagenesis was used to diversify the γ-glutamyl kinase (GK)-coding gene <em>proB</em> in <em>C. glutamicum</em> S9114 and an optimized rare codon-based selection was used to isolate the L-proline high-yielding strain with optimal GK variant. Triple-mutant GK<sup>E74K/G149K/V150M</sup> was identified with high substrate affinity and catalytic efficiency for producing L-proline. The resultant strain <em>C. glutamicum</em> Pro-7 produced 94.2 ± 5.6 g/L of L-proline with productivity of 1.96 g/(L·h) and a yield of 0.316 g/g. Subsequently, the molecular mechanisms involved in high L-proline production in strain Pro-7 was discovered, indicating that ATP and NADPH supply are also the key factors for the L-proline biosynthesis besides GK. Thus, <em>in situ</em> directed evolution of key genes in genome by EvolvR-mediated mutagenesis and rare codon-based selection provides a new direction and reference to construct industrial-strength strains.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"226 ","pages":"Article 109982"},"PeriodicalIF":3.7000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25003560","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
An efficient evolution and selection system is vital for constructing the high added-value products hyper-producers in fermentation industry. Herein, an innovative EvolvR-mediated mutagenesis was used to diversify the γ-glutamyl kinase (GK)-coding gene proB in C. glutamicum S9114 and an optimized rare codon-based selection was used to isolate the L-proline high-yielding strain with optimal GK variant. Triple-mutant GKE74K/G149K/V150M was identified with high substrate affinity and catalytic efficiency for producing L-proline. The resultant strain C. glutamicum Pro-7 produced 94.2 ± 5.6 g/L of L-proline with productivity of 1.96 g/(L·h) and a yield of 0.316 g/g. Subsequently, the molecular mechanisms involved in high L-proline production in strain Pro-7 was discovered, indicating that ATP and NADPH supply are also the key factors for the L-proline biosynthesis besides GK. Thus, in situ directed evolution of key genes in genome by EvolvR-mediated mutagenesis and rare codon-based selection provides a new direction and reference to construct industrial-strength strains.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.